0001140361-17-029083.txt : 20170728 0001140361-17-029083.hdr.sgml : 20170728 20170728150829 ACCESSION NUMBER: 0001140361-17-029083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170726 FILED AS OF DATE: 20170728 DATE AS OF CHANGE: 20170728 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greiner Michael CENTRAL INDEX KEY: 0001520392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 17989665 MAIL ADDRESS: STREET 1: C/O VISTAPRINT STREET 2: 95 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 4 1 doc1.xml FORM 4 X0306 4 2017-07-26 0 0001275187 ANGIODYNAMICS INC ANGO 0001520392 Greiner Michael 14 PLAZA DRIVE LATHAM NY 12110 0 1 0 0 EVP and CFO Common Stock 2017-07-26 4 A 0 6193 0 A 16193 D Non-Qualified Stock Option (right to buy) 16.55 2017-07-26 4 A 0 21762 0 A 2018-07-26 2027-07-26 Common Stock 21762 21762 D Performance Right 2017-07-26 4 A 0 12387 0 A Common Stock 12387 12387 D This acquisition of 6,193 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 6,193 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021. These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021. Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited. /s/ Stephen A. Trowbridge, Attorney in Fact 2017-07-28